2023-06-22 11:56:46
Home > Remedies > Waves once morest chronic pain written on June 22, 2023 at 1:56 p.m. Neuromodulation by millimeter waves aims to stimulate the release of endorphins. Article published in the newspaper nº 114
A non-invasive, non-drug, side-effect-free and visibly effective solution to combat chronic pain in general and osteoarthritis in particular? That’s what promises the company Remedee Labs. How ? By using the technology known as millimeter wave neuromodulation (WMO).
Discovered in 1970, this technique proved itself on millions of patients before being abandoned in favor of analgesics. With the success that we know: side effects, dependence and addiction, tolerance phenomena, risk of overdose.
One might think that it is to alleviate this great disaster that the OMMs are resurfacing. Two other parameters can also be evaluated. The first is that technological developments and work studying the mechanisms of OMMs are consolidating the interest of this therapeutic approach. The second, “is that the knowledge and recognition of chronic pain have greatly evolved in recent years “*. So much so that in 2022 it gained the dimension of chronic pathology in its own right.
Read also Waves and health: where are we?
Furthermore, to the binary scheme which only took into account nociceptive and neuropathic pain (concerning the sensory fibers for the former, the nerves for the latter), a third type of pain has been added: nociplastic pain. Described in 2017, they arise despite the absence of clear evidence of injury or disease. And it is because of their poor response to painkillers that research places great hopes in the therapeutic approach by OMM.
The purpose of millimeter wave neuromodulation is to stimulate the release of endorphins – the natural painkillers produced by the body. Gone are the big hospital machines of the 1980s. Today, a 60 GHz signal is emitted by a small module slipped into a bracelet, the waves of which only penetrate the superficial layer of the skin, unless of 0.5 mm, to target subcutaneous nerve endings. A clinical trial conducted by the CHU of Grenoble-Alpes on 60 volunteers suffering from osteoarthritis shows “ that regular use (1 to 3 times a day) of the bracelet for three months leads to a significant reduction in pain on the visual analog scale (VAS) in patients with peripheral osteoarthritis “, according to the statements of Dr. Grange, rheumatologist and one of the authors of the trial. In addition, the associated disorders (sleep disorders, overall quality of life) improved significantly. These results, presented at European Congress of Rheumatology will soon be published. And already, the team is working on a clinical trial on the fibromyalgia.
Bibliographic references
Under no circumstances is the information and advice offered on the Alternative Santé site likely to replace a consultation or a diagnosis formulated by a doctor or a health professional, who are the only ones able to adequately assess your state of health.
1688965813
#Waves #chronic #pain